Given recent findings that the prognostic value of TP53 may depend upon subtype,14 future analyses integrating subtype and TP53 status will help ascertain the role of this pathway in breast cancer outcomes and race-ethnicity mortality disparities. The gene discussed is TP53; the disease is breast carcinoma.